AzTrials
AzTrials

Frail EldersSingaPACENCT01568801

Evaluation of the Singapura Program of All Inclusive Care for the Elderly (SingaPACE) Demonstration Project

A study testing SingaPACE in people with Frail Elders, run by National University of Singapore at 2 sites in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a RCT studying the effectiveness of the Singapore Program for All Inclusive Care for the Elderly (SingaPACE) demonstration project over a 36 month period. SingaPACE is modelled on the US PACE home and community based service that acts as an alternative to institutional care. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Frail Elders
What is being tested?
SingaPACE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesSingapore
Study dates
Aug 2011to Jul 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals aged 60 and above;
  • The frail elderly classified as high Category2 - Category 3 under the Residence Assessment Form(RAF);
  • Are willing to enroll in SingaPACE if they were selected in a fair lottery draw or to be followed up similarly over 36 months if not selected;
  • Residing within the Bukit Merah catchment area;

Who cannot join

  • Bed Bound;
  • Are undergoing dialysis treatment,
  • Radiotherapy or chemotherapy; or
  • Have behavioral and psychological symptoms of dementia(BPSD)prior to enrollment in the research study.

Trial locations and contacts

2 sites in 1 country.

Singapore2 sites
  • NTUC Eldercare

    Singapore

  • Tiong Bahru Central Plaza

    Singapore

Other trials in Singapore

About this study

Official title: Evaluation of the Singapura Program of All Inclusive Care for the Elderly

This is a RCT studying the effectiveness of the Singapore Program for All Inclusive Care for the Elderly (SingaPACE) demonstration project over a 36 month period. SingaPACE is modelled on the US PACE home and community based service that acts as an alternative to institutional care. The comparator is best referrals for care as currently arranged through the Agency for Integrated Care (AIC) and referred by medical social workers. This research aims to determine how the SingaPACE model of health and social care affects use of emergency and acute care hospital services, institutional care, the quality of life (QOL) and satisfaction of the participants aged 60+ and their caregivers.

The hypotheses to be tested are:

Read more

H01: The elderly in SingaPACE will have fewer admissions to accident \& emergency (A\&E) hospitalization than the elderly who are not in SingaPACE.

H02: The elderly in SingaPACE will have fewer admissions to acute care hospitalization than the elderly who are not in SingaPACE.

H03: The elderly in SingaPACE will delay first admission to institutionalized nursing home care more than the elderly who are not in SingaPACE.

H04: The elderly in SingaPACE clients will have a higher QOL compared to the elderly who are not in SingaPACE.

H05: Caregivers of the elderly in SingaPACE will have a lower care-giving burden compared to caregivers of the elderly who are not in SingaPACE.

Read the detailed description
  • Recruitment

Potential subjects will be identified from i) inpatients referred prior to discharge and ii) outpatients to medical social workers from Singapore General Hospital (SGH) and Alexandra Hospital (AH). After confirming study eligibility the medical social worker will inform the potential subject about the study; after obtaining informed consent, the medical social worker will make a telephone call to the Duke - NUS research fellow who will then carry out the randomization process, assigning the subject to either the intervention group or the control group.

  • Sites

The SingaPACE program will be located at 298, Tiong Bahru Road, #15-01/06 Central Plaza and at NTUC Eldercare, Block 117, Bukit Merah View.

  • Procedures
  • Randomization will be stratified at each recruitment site by gender, assuring equal numbers of men and women in each study arm; and by hospital assuring equal number of patients from SGH and AH in each study arm. 20 participants will enter the study (10 per arm) each month over a proposed 4-month recruitment period. If the recruitment rate is lower than expected, the recruitment period will be extended.
  • Individuals in the intervention group will have a program of services based on intake and ongoing evaluation using interRAI by the SingaPACE assessment team. Services included in the integrated available mix are:
  • Case management across the continuum of care
  • Medical care by the SingaPACE physician
  • Home nursing (e.g., for administering parenteral medication, wound care, assessment of health status, nutrition)
  • Home care (e.g., for assistance with ADL)
  • Physiotherapy
  • Occupational therapy
  • Psychosocial care and counseling by social workers
  • Transportation to care and support services
  • Emergency housing and beds - public hospital acute bed substitution 24 hour doctor / nurse phone coverageIf individuals in the intervention group leave the SingaPACE program, they will still continue to be tracked as a part of intention-to-treat analysis. Patients who die over the 36 months will be counted as drop outs. While the program can have new replacements for patients who have died, new participants will not be counted as a part of the intervention group in this research study.
  • Individuals randomized to the control arm will be referred to the medical social worker for referral to community services as usual. The control group will be interviewed on their medical history, healthcare utilization and expenditure data. The data collected will be complemented by data that may be made available by the VWO providing home and community care to the control group. Such VWO data may possibly include assessments using RAF.

If participants from the control group switch from a VWO community care program to another VWO community care program, they will still continue to be tracked and included in the intention-to-treat analysis. For participants who die over the period of study, they will be counted as loss to follow-up.

The control group will receive community care services referred by the SGH MSW:

  • VWO community care
  • GPs
  • Polyclinics
  • Specialist Outpatient Clinics
  • Traditional Chinese Medicine or herbal treatments
  • Supportive care arrangements of the family, relatives and friends
  • All participants will be tracked over a 36-month period starting August 2011. Following the US PACE impact evaluation from 1998 observations of all patients will be made at the beginning of the intervention and follow up at 6 month intervals (Chatterji et al. 1998; Irvin, Massey and Dorsey 1997; White, Abel and Kidder, 2000).

Analysis The main outcome measure is number of EMT events, A\&E events and acute care events over the 36 month period. This is the primary endpoint.

The secondary endpoints to be studied are time to first admission to nursing home over the 36 month period, LOS in A\&E; LOS in acute care; patient QOL and satisfaction with care; monthly utilization and costs; healthcare expenditure (out-of-pocket) and financing; and caregiver satisfaction / well being. There will be both unadjusted and adjusted measures. For time to first admission to nursing home, survival analysis specifically Cox Proportional Hazards regressions and intention-to-treat analysis will be carried out.

Since our study tracks participants over a period of 36 months, the first potential concern is participants in the control group who may be lost to follow-up 6 months after discharge which is when the MSW will close the care management files for patients. After the 6 months, the control group may for various reasons cease to receive community care unless they are in a VWO program that has care management. To minimize this difficulty, the available coordinated care management VWOs in the Bukit Merah catchment area will be provided with the list of names of the control group for oversight. Should any of the participants drop out of a community care program, the care coordinators can assist in enrolling the older adult in another care program should the participant decide that s / he would like to continue in a care program.

Statistical justification and the means by which data will be analyzed and interpreted

For the hypothesis to be tested, H03: Frail elderly in SingaPACE will have delayed first admission to institutionalized residential care nursing home relative to the frail elderly who are not in SingaPACE, survival analysis will be carried out. Shoenfeld's formula gives the total number of first nursing home admissions necessary to achieve 80% power as a function of the hazard ratio 32/(log HR)2. Assuming a hazard ratio of 0.35, along with first admission probabilities of 20% and 50% in SingaPACE and non-SingaPACE groups respectively, approximately 28 total admissions and therefore total participants (40 in each group) will be needed.

For the hypotheses H01: The elderly in SingaPACE will tend to have fewer admissions to accident \& emergency (A\&E) hospitalization than the elderly who are not in SingaPACE; H02: The elderly in SingaPACE will have fewer admissions to acute care hospitalization than the elderly who are not in SingaPACE; H04: The elderly in SingaPACE clients will have an enhanced QOL and satisfaction compared to the elderly who are not in SingaPACE; and H05: Caregivers of the elderly in SingaPACE will have a lower care-giving burden compared to caregivers of the elderly who are not in SingaPACE, Wilcoxon rank sum tests will be carried out. Assuming that observations from one group will exceed observations from the other group at least 55% of the time, each of these tests will have greater than 80% power for detecting a difference between the groups.

The analytical strategy will consist of hypothesis testing for each of the five individual hypotheses and intention-to-treat analysis. Also there will be an examination of the distributions of the main outcomes across all participants in each arm over 36 months. This will be complemented by a meta-analysis of the effectiveness of PACE programs in the US and Singapore.

Conditions
Frail Elders
Being tested
SingaPACE
Keywords
Integrated Services, Health Services for the Elderly, Community Services

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SingaPACEBehavioural

    Individuals in the intervention group will go through an integrated program of community based health and social care, based on intake and ongoing evaluation by the SingaPACE team.

Study groups in NCT01568801
Study groupRoleWhat they receive
Control GroupNo interventionIndividuals randomized into the control arm will receive usual community care services referred by the social worker from SGH and AH.
Intervention GroupExperimentalIndividuals in the intervention group will go through an integrated program of community based health and social care based on intake and ongoing evaluation by the SingaPACE team.
Receives: Behavioral: SingaPACE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of EMT and acute care events

    The primary outcome measure will be the number of EMT events, A\&E visits or acute care hospitalizations captured based on the following possible sequence of events:

    • The number of EMT events or
    • The number of EMT events leading to A\&E events or
    • The number of EMT events leading to A\&E events that lead to acute care hospitalizations or
    • The number of A\&E events or
    • The number of A\&E events that lead to acute care hospitalizations or
    • The number of acute care hospitalizations

    Measured: 36 months

Secondary outcomes (4)
  1. Admission to institutionalized nursing home

    From randomization point, time to first admission to nursing home over the 36 month period

    Measured: 36 months

  2. Length of stay in acute care

    For each acute care hospitalization, the length of stay

    Measured: 36 months

  3. Patient Quality of Life

    Patient QOL assessed using EQ-5D at 6 month intervals for the given time frame

    Measured: 36 months

  4. Caregiver burden

    Using the Zarit Caregiver Burden measure, assess changes to caregiver (spouse, family members, friends) burden at 6 month intervals for the given time frame

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2012 (estimated)
  2. Study startAug 2011
  3. Primary completionJul 2014
  4. Study completionJul 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01568801
Sponsor's protocol ID
2011/381/A
Other IDs
2011/381/A
Acronym
SingaPACE
Status last verified
Apr 2015
First submitted
29 Mar 2012
Last updated
16 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing SingaPACE in people with Frail Elders, run by National University of Singapore at 2 sites in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of EMT and acute care events (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in